StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences stock opened at $0.00 on Monday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.02.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.